SCHEMBL5936616

SCHEMBL5936616

CCCNCCc1c2c(nc3ccccc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 18/20 0.82
MEN1 O00255 3/20 0.65
KMT2A Q03164 3/20 0.65
ALDH1A1 P00352 3/20 0.62
GLA P06280 3/20 0.62
KDM4E B2RXH2 2/20 0.62
TP53 P04637 2/20 0.62
HPGD P15428 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
STAT6 P42226 1/20 0.62
CHEK1 O14757 1/20 0.62
HDAC3 O15379 1/20 0.62
ABCC4 O15439 1/20 0.62
GMNN O75496 1/20 0.62
LMNA P02545 1/20 0.62
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62
HNRNPA1 P09651 1/20 0.62
GAA P10253 1/20 0.62
ALOX15 P16050 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4234927 0.99 TOP1 (0.81) TOP1MEN1KMT2AALDH1A1GLA
SCHEMBL22843978 0.92 TOP1 (0.82) TOP1MEN1KMT2AALDH1A1GLA
SCHEMBL4453581 0.92 TOP1 (0.90) TOP1MEN1KMT2AALDH1A1GLA
SCHEMBL1728533 0.90 TOP1 (1.00) TOP1MEN1KMT2AALDH1A1GLA
Belotecan SCHEMBL29378860 0.90 TOP1 (0.79) TOP1MEN1KMT2AALDH1A1GLA
Belotecan SCHEMBL18983 0.90 TOP1 (0.79) TOP1MEN1KMT2AALDH1A1GLA
Belotecan SCHEMBL21410040 0.90 TOP1 (0.79) TOP1MEN1KMT2AALDH1A1GLA
SCHEMBL11070279 0.90 TOP1 (0.86) TOP1MEN1KMT2AALDH1A1GLA
SCHEMBL27606708 0.90 TOP1 (0.86) TOP1MEN1KMT2AALDH1A1GLA
Belotecan SCHEMBL31499426 0.89 TOP1 (0.78) TOP1MEN1KMT2AALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060135546-A1 Methods for the purification of 20(S)- camptothecin CYMBIO PHARMA PVT. LTD. (IN) 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135546-A1 Methods for the purification of 20(S)- camptothecin TOP2A, TOP2B, TOP1 TOP1 3/4885MEN1 1966/4885KMT2A 2488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.